Literature DB >> 11431181

Recreational drug use: a neglected risk factor for end-stage renal disease.

T V Perneger1, M J Klag, P K Whelton.   

Abstract

Case series have suggested that heroin and cocaine users are at increased risk for renal failure, but the contribution of heroin and other addictive drugs to the incidence of end-stage renal disease (ESRD) in the general population remains unknown. To clarify this issue, we conducted a case-control study in the general population to examine associations between drug use and treated ESRD. Cases were 716 patients who started therapy for ESRD in 1991, identified through a regional registry. Controls were 361 persons of similar age (20 to 65 years) selected by random digit dialing. Main risk factors examined were the lifetime use of heroin, cocaine, and other addictive drugs, assessed by telephone interview. After adjustment for age, sex, race, socioeconomic status, and history of hypertension and diabetes, persons who had ever used heroin or other opiates (any amount) were at increased risk for ESRD (adjusted odds ratio, 19.1; 95% confidence interval, 1.7 to 208.7). After adjustment for the same sociodemographic and medical history variables, the use of cocaine or crack and psychedelic drugs was also associated with ESRD, but these associations could not be separated from the effects of heroin use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431181     DOI: 10.1053/ajkd.2001.25181

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  15 in total

Review 1.  End stage renal disease.

Authors:  Yoshio N Hall; Glenn M Chertow
Journal:  BMJ Clin Evid       Date:  2007-10-17

Review 2.  End-stage renal disease.

Authors:  Maaz Ahmed Abbasi; Glenn M Chertow; Yoshio N Hall
Journal:  BMJ Clin Evid       Date:  2010-07-19

3.  Illicit drug use, hypertension, and chronic kidney disease in the US adult population.

Authors:  Sanjeev K Akkina; Ana C Ricardo; Amishi Patel; Arjun Das; Lydia A Bazzano; Carolyn Brecklin; Michael J Fischer; James P Lash
Journal:  Transl Res       Date:  2012-06-23       Impact factor: 7.012

4.  Lifetime Cocaine and Opiate Use and Chronic Kidney Disease.

Authors:  Tessa Novick; Yang Liu; Anika Alvanzo; Alan B Zonderman; Michele K Evans; Deidra C Crews
Journal:  Am J Nephrol       Date:  2016-10-28       Impact factor: 3.754

Review 5.  Chronic kidney disease care in the US safety net.

Authors:  Delphine S Tuot; Vanessa Grubbs
Journal:  Adv Chronic Kidney Dis       Date:  2015-01       Impact factor: 3.620

6.  Chronic Kidney Disease from Polyvinylpyrrolidone Deposition in Persons with Intravenous Drug Use.

Authors:  Ida V Stalund; Heidi Grønseth; Finn P Reinholt; Einar Svarstad; Hans-Peter Marti; Sabine Leh
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-16       Impact factor: 8.237

7.  Clinical care of the HIV-infected drug user.

Authors:  R Douglas Bruce; Frederick L Altice
Journal:  Infect Dis Clin North Am       Date:  2007-03       Impact factor: 5.982

Review 8.  Race and kidney disease: role of social and environmental factors.

Authors:  Chike M Nzerue; Haliu Demissochew; J Kevin Tucker
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

9.  Overexpression of Delayed Rectifier K(+) Channels Promotes In situ Proliferation of Leukocytes in Rat Kidneys with Advanced Chronic Renal Failure.

Authors:  Itsuro Kazama; Yoshio Maruyama; Yasuhiro Endo; Hiroaki Toyama; Yutaka Ejima; Mitsunobu Matsubara; Shin Kurosawa
Journal:  Int J Nephrol       Date:  2012-05-31

10.  Social adaptability and substance abuse: predictors of depression among hemodialysis patients?

Authors:  Paulo Roberto Santos; Francisco Plácido Nogueira Arcanjo
Journal:  BMC Nephrol       Date:  2013-01-15       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.